Takeda has bought a licence for a coeliac disease drug from COUR Pharmaceuticals, after the US biotech announced supportive phase 2a trial data. Gastrointestinal diseases are one of the Japanese ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

This repository provides unofficial binary wheels for Pygame for Python on Windows. The files are unofficial (meaning: informal, unrecognized, personal, unsupported, no warranty, no liability, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Coursera (COUR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Have you ever wished you could generate interactive websites with HTML, CSS, and JavaScript while programming in nothing but Python? Here are three frameworks that do the trick. Python has long had a ...

More than a decade after its founding, Cour Pharmaceuticals has raised $105 million in series A funding as it advances two immune disease drugs through clinical trials. Roche, Pfizer, and Bristol ...

Ewan has been a content writer since 2020, and loves nothing more than discussing all things gaming. While he's been playing games all his life, he has a particular interesting in anything even ...

CNP-104 is a biodegradable nanoparticle that previously received fast track designation from FDA in January 2022, which would eventually make it eligible for accelerated approval and priority review.

Glenys says she has lived a fantastic life and is still excited by her work Acclaimed artist Glenys Cour is just weeks away from her 101st birthday and cannot believe her good fortune. She has built ...